MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 30, 2005; DOI: 10.1124/mol.104.010124


0026-895X/05/6806-1678-1687$20.00
Mol Pharmacol 68:1678-1687, 2005

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.010124v1
68/6/1678    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amireault, P.
Right arrow Articles by Dubé, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amireault, P.
Right arrow Articles by Dubé, F.

Intracellular cAMP and Calcium Signaling by Serotonin in Mouse Cumulus-Oocyte Complexes

Pascal Amireault, and François Dubé

Département d'Obstétrique-Gynécologie, Université de Montréal, and Centre de Recherche, Centre Hospitalier de l'Université de Montréal-Hôpital Saint-Luc, Montréal, Québec, Canada

Received January 9, 2005; accepted August 30, 2005


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
cAMP and intracellular Ca2+ are important second messengers involved in mammalian follicular growth and oocyte meiotic maturation. We investigated the capacity of the neurohormone serotonin (5-hydroxytryptamine, 5-HT) to regulate intracellular cAMP and Ca2+ in mouse oocytes and surrounding cumulus cells. On the basis of a reverse transcription-polymerase chain reaction study, 5-HT7 receptor mRNA is expressed in cumulus cells, oocytes, and embryos up to the four-cell stage, and 5-HT2A and 5-HT2B receptor mRNAs are expressed in cumulus cells only, whereas 5-HT2C, 5-HT4, and 5-HT6 receptors are expressed in neither oocytes nor cumulus cells. The addition of 5-HT (10 nM to 10 µM) to isolated metaphase II oocytes had no effect on their internal cAMP or Ca2+ levels, whereas it caused dose-dependent cAMP and Ca2+ increases in cumulus cells. This cAMP increase in cumulus cells could be mimicked by 5-HT agonists with the following order of potency: 5-HT > 8-hydroxy-2-(di-n-propylamino) tetralin = {alpha}-methyl-5-HT = 5-carboxamidotryptamine maleate > 2-[1-(4-piperonyl)piperazinyl]benzo-triazole, thereby supporting a preferential involvement of 5-HT7 receptors. As measured with cumulus cells preloaded with fura-2/acetoxymethyl ester (AM), the addition of 5-HT also caused dose-dependent Ca2+ increases, which were probably linked to detected 5-HT2A and 5-HT2B receptors. Adding the Ca2+ ionophore ionomycin to cumulus cells resulted in both Ca2+ and cAMP elevations, whereas preincubation of cells with the Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA)-AM abolished the 5-HT-induced Ca2+ increase and reduced the cAMP increase, indicating cross-talk between the 5-HT-sensitive Ca2+ and cAMP pathways. Our results show that 5-HT may be a local regulator in mouse cumulus-oocyte complexes through its actions on cAMP and Ca2+ signaling, as mediated by 5-HT2A, 5-HT2B, and 5-HT7 receptors.


cAMP and intracellular Ca2+ are involved in several important reproductive functions in mammals. One role of cAMP, in the mammalian ovary, is the maintenance of the oocytes arrested in prophase I until ovulation. The high internal cAMP required for the maintenance of oocyte meiotic arrest seems to be provided, in part, by granulosa cells tightly connected to oocytes through gap junctions, allowing the free transfer of both cAMP and Ca2+ ions (Conti et al., 2002Go; Webb et al., 2002aGo,bGo). In the whole follicle, cAMP, along with intracellular Ca2+, is also involved in follicle-stimulating hormone-induced expressions of cytochrome P450 sidechain cleavage enzyme, aromatase, and LH receptor in granulosa cells (Gore-Langton and Armstrong, 1988Go; Leung and Steele, 1992Go). LH also promotes cAMP and Ca2+ increases in theca cells, leading to CYP11A and CYP17 gene expressions (Gore-Langton and Armstrong, 1988Go; Leung and Steele, 1992Go). At fertilization, the oocyte undergoes an initial Ca2+ increase, followed by periodic oscillations that are essential for meiosis reinitiation, cortical granule exocytosis, and proper embryo development (Kline and Kline, 1992Go; Lawrence et al., 1998Go). Thus, cAMP and Ca2+ signaling is required not only for various functions within both oocytes and their surrounding granulosa cells but also for their intimate coordination one with the other. Despite this central role of Ca2+ and cAMP, little is known about their upstream regulation by potential ligands and receptors to be identified that might influence their cellular levels.

One such potential ligand is serotonin (5-hydroxytryptamine, 5-HT), whose action is well known as a regulator of spawning and oocyte maturation in several invertebrates (Colas and Dubé, 1998Go; Stricker and Smythe, 2000Go) and of follicular growth in fishes (Cerda et al., 1998Go), but whose potential functions in mammalian reproductive tissues, through Ca2+ and cAMP signaling, are poorly documented. Among the indications that 5-HT might be such a local regulator is its detection in female rodent genital tracts (Amenta et al., 1992Go) and in human follicular fluid (Bodis et al., 1993Go). Moreover, 5-HT has also been reported recently in isolated mouse oocytes and embryos (Il'kova et al., 2004Go; Amireault and Dubé, 2005Go) and in surrounding cumulus cells that also possess the rate-limiting enzyme tryptophan hydroxylase for 5-HT production, thus making these cells a potential immediate direct source of 5-HT (Amireault and Dubé, 2005Go). In addition, in vitro, 5-HT promotes estradiol secretion by rat (Tanaka et al., 1993Go) and hamster (Terranova et al., 1990Go) preovulatory follicles and progesterone secretion by cultured bovine luteal cells (Battista et al., 1987Go). Finally, it was also shown that an antidepressant-sensitive specific 5-HT transporter was active in mouse oocytes and embryos to accumulate external 5-HT (Amireault and Dubé, 2005Go). All of these observations suggest the existence of a local and functional serotonergic network in reproductive tissues in general and in mouse cumulus-oocyte complexes in particular. A proper identification of the specific 5-HT receptors involved in the regulation of this serotonergic network remains to be established.

Mammalian 5-HT receptors are divided into seven subfamilies (5-HT1-7) sharing common sequences, pharmacological properties, and signaling pathways, and most of them are G-protein-coupled receptors regulating cAMP or intracellular Ca2+. For example, 5-HT1 receptors are coupled preferentially to Gi/o to inhibit cAMP formation (Barnes and Sharp, 1999Go), whereas 5-HT4, 5-HT6, and 5-HT7 receptors are coupled to Gs and, hence, positively regulate adenylate cyclase, causing cAMP increases when activated (Hamblin et al., 1998Go). 5-HT2 receptors are coupled to Gq and are linked to phospholipase C, thus mobilizing intracellular Ca2+ (Roth et al., 1998Go). Only a few of these 5-HT receptor subtypes have been reported in mammalian reproductive tissues and cells. First, the 5-HT7 receptor was detected in cultured human granulosa-lutein cells (Graveleau et al., 2000Go), in which 5-HT promotes the expected cAMP elevation. In addition, in isolated metaphase II hamster oocytes, 5-HT induces intracellular Ca2+ oscillations sensitive to 5-HT2 antagonists (Miyazaki et al., 1990Go), suggesting the presence of this receptor type in oocytes. Moreover, a polymerase chain reaction (PCR)-serial analysis of gene expression study reported the expression of 5-HT2A receptor mRNA in human oocytes (Neilson et al., 2000Go), and a reverse transcription (RT)-PCR analysis suggested the expression of 5-HT1D receptor mRNA in mouse oocytes and embryos (Vesela et al., 2003Go).

All of these findings support an involvement of 5-HT and some of its receptors in various key processes in oocytes and surrounding cells, probably involving cAMP and/or Ca2+ signaling. We therefore decided to clarify the effects of 5-HT on cAMP and Ca2+ levels in mouse oocytes and cumulus cells and to identify the 5-HT receptors regulating these effects, with special attention given to those two Gq and Gs subtypes, 5-HT2 and 5-HT7, detected previously in other mammalian reproductive tissues or cells.


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Oocyte and Embryo Collection. Fully grown germinal vesicle stage oocytes, ovulated metaphase II oocytes, and preimplantation embryos at various stages were obtained from 3- to 4-week-old female B6C3F1 mice (Charles River, Margate, Kent, UK) after standard gonadotropin injection. For germinal vesicle-stage oocytes, the mice were primed with 5 IU of pregnant mare's serum (Sigma-Aldrich, St. Louis, MO), and cumulus-enclosed, fully grown oocytes were collected 46 to 48 h later by puncturing the antral follicles with a 30-gauge needle under a dissecting microscope in M2 medium containing 100 µM 3-isobutyl-1-methylxanthine (IBMX). When needed, the cumulus cells were removed by repeated pipetting with a small-bore pipette. For metaphase II-arrested eggs, the mice were primed with 5 IU of pregnant mare's serum, followed (44-48 h later) by 5 IU of human chorionic gonadotropin (pregnyl-human chorionic gonadotropin; Organon Canada Ltd., Scarborough, ON, Canada) injection, and cumulus-enclosed eggs (COC-metaphase II) were collected from the oviduct 18 to 20 h later in M2 medium. When needed, the cumulus cells were dispersed in M2 medium containing 10 mg/ml bovine testis hyaluronidase (Sigma-Aldrich), and the eggs were washed and collected in M2 medium. For embryos, female mice were submitted to the gonadotropin protocol and were allowed to mate with a male the night after the second injection. Embryos were collected by flushing the oviducts or uteri with M2 medium by using a 30-gauge needle mounted on a syringe. The timing of embryo collection was as follows: one-cell embryo, 19 h after human chorionic gonadotropin; two-cell embryo, 43 h; four-cell embryo, 50 h; eight-cell embryo, 67 h; morula, 74 h; and early blastocysts, 91 h.

mRNA Isolation and RT-PCR. Collected cells were incubated in acidic Tyrode's solution (Sigma-Aldrich) to remove the zona pellucida of germinal vesicle oocytes, metaphase II eggs, and one-cell embryos. The cells were kept in a minimum of M2 medium at -80°C until mRNA isolation. mRNAs of 10 oocytes, 10 embryos, or cumulus cells from 30 to 50 COC-metaphase II were isolated according to the microscale protocol with the Dynabeads mRNA Direct kit (Dynal Biotech, Lake Success, NY). The mRNAs were reverse-transcribed using Superscript II enzyme (Invitrogen, Carlsbad, CA) in a 20-µl reaction at 42°C for 45 min, to construct a cDNA library immobilized on beads, following the manufacturer's specifications. The first PCR run (50 µl) was performed on cDNA beads in suspension. The PCR program, of 26 cycles with a hot start, consisted of denaturation of 90 s at 95°C, primer annealing of 90 s at 65°C (5-HT7 and 5-HT2A), or 60°C (5-HT2B, 5-HT2C, 5-HT4, and 5-HT6), and primer extension of 90 s at 72°C (last primer extension of 15 min). The second PCR run was performed with .10 µl of products from the first amplification and the same PCR program (28 cycles). For 5-HT7, two pairs of primers in a nested PCR strategy produced final amplicons of 174 bp (5-HT7a), 179 bp (5-HT7b), or 272 bp (5-HT7c). The primers used were the following: first forward, 5'-cagccaaacacaagttctcag-3'; first reverse, 5'-cccctgttctgcattacttctt-3'; second forward, 5'-tccagtgccagtaccggaatatcaac-3'; and second reverse, 5'-tacttcttctccagggttccgctct-3'. For 5-HT2A, two pairs of primers were used in a nested PCR strategy to produce amplicons of 627 bp (forward, 5'-tcttctccacggcatccatcatgcac-3', and reverse, 5'-caaacacattgagcagggctccaatgac-3') and 419 bp (forward, 5'-accatagccgcttcaactccagaacc-3', and reverse, 5'-tgctttttgctcattgctgatggactgc-3'). For 5-HT2B, two pairs of primers were used in a nested PCR strategy to produce amplicons of 678 bp (forward, 5'-tgtctgaacaaagcacaacttctgagc-3', and reverse 5'-ccatgatggtgagaggtacgaagaaag-3') and 451 bp (forward, 5'-actcagtagcagaggaaatgaagcaga-3', and reverse, 5'-gcgatgcctattgaaattaaccatacc-3'). For 5-HT2C, two pairs of primers were used in a nested PCR strategy to produce amplicons of 658 bp (forward, 5'-gcagtacgtaatcctattgagcatagcc-3', and reverse, 5'-ttttgttgaagagagtgtacaccagagg-3') and 411 bp (forward, 5'-ttcttcatcccgttgacaattatgg-3', and reverse, 5'-cacatagccaatccaaacaaacaca-3'). For 5-HT4, two pairs of primers were used in a nested PCR strategy to produce amplicons of 649 bp (forward, 5'-ctaatgtgagttccaacgagggtttc-3', and reverse, 5'-tgctccttagcagtgacatagattcg-3') and 512 bp (forward, 5'-gttccttgcagtggttatcctgatg-3', and reverse, 5'-tgatagcatagggcttgttgaccat-3'). For 5-HT6, two pairs of primers were used in a nested PCR strategy to produce amplicons of 790 bp (forward, 5'-caacacgtctaacttcttcctggtgt-3', and reverse, 5'-gatgatagggttcatggtgctattacag-3') and 454 bp (forward, 5'-ctaacttcttcctggtgtcgctcttc-3', and reverse, 5'-aagatcctgcagtaggtgaagcagat-3'). Primers for {beta}-actin as positive controls yielded 540-bp (forward, 5'-gtgggccgctctaggcaccaa-3', and reverse, 5'-ctctttgatgtcacgcacgatttc-3') and 277-bp (forward, 5'-tgtgatggtgggaatgggtcagaaggac-3', and reverse, 5'-tacgtacatggctggggtgttgaagg-3') amplicons. Twenty-five microliters of each reaction was loaded on agarose gel stained with ethidium bromide. Each amplification was executed at least three times, yielding similar results. All PCR products obtained were cloned in pCRII (Invitrogen) and were sequenced on both strands using the Université Laval sequencing service to confirm the sequence.

Indirect Immunofluorescence Confocal Microscopy for 5-HT7 and 5-HT2A Detection. Oocytes and embryos were collected and treated as described above and then fixed in fresh paraformaldehyde 4% for 30 min at room temperature. They were washed three times for 5 min in Dulbecco's phosphate-buffered saline (D-PBS) before a 1-h blocking step in D-PBS/milk 5%/Triton 0.5%/normal goat serum 5%. They were next incubated overnight at 4°C with a primary antibody in D-PBS/milk 1%/Triton 0.1%/normal goat serum 1%. After three washes in D-PBS, the oocytes and embryos were incubated for 1 h at room temperature in a Cy-3-conjugated goat anti-rabbit antibody (1/2000; Jackson ImmunoResearch Laboratories Inc., West Grove, PA) and washed three times in D-PBS. Finally, metaphase II-arrested eggs, COC-metaphase II, cumulus cells, and four-cell embryos were mounted with Fluoromount (Electron Microscopy System), and blastocysts were mounted with 50% glycerol in D-PBS. Images were collected with a 63x/1.4 oil differential interference contrast plan-apochromat objective and a Zeiss Axiovert 100M microscope coupled with the LSM510 system (Carl Zeiss Inc., Thornwood, NY).

For 5-HT7, a rabbit anti-rat antibody directed against amino acids 8 to 23 (Calbiochem, San Diego, CA) and diluted 1/200 served as primary antibody. For 5-HT2A, a rabbit anti-rat antibody directed against amino acids 22 to 41 (Calbiochem) was diluted 1/150. Controls without the first antibody were also included for each cell type tested.

Western Blotting. For each detection of 5-HT2A and 5-HT7, approximately 300 and 500 oocytes, respectively, and corresponding surrounding cumulus cells were lysed in 30 µl of 0.5% SDS and kept at -80°C until electrophoresis. The frozen samples were diluted in 4x sample buffer, loaded onto 7.5% SDS-polyacrylamide gel, run at 200 V for 45 min, and transferred to a polyvinylidene difluoride membrane. The membrane was blocked with 5% milk and 0.1% Tween 20 in D-PBS for 1 h at room temperature before overnight incubation at 4°C in fresh blocking solution containing the appropriate diluted first antibody. The membrane was then washed three times in 0.1% Tween 20 in D-PBS and incubated in fresh blocking solution containing the appropriate diluted second antibody. Finally, the membrane was washed several times in 0.1% Tween 20 in D-PBS before the detection protocol using the Enhanced Chemiluminescence Plus assay kit (GE Healthcare, Little Chalfont, Buckinghamshire, UK). The same 5-HT7 (1/500) and 5-HT2A (1/500) antibodies as for indirect immunofluorescence detection were deployed for Western blotting with a goat anti-rabbit-horseradish peroxidase secondary antibody (1/20,000; Bio-Rad, Hercules, CA).

cAMP Extraction and Measurement after Cell Treatments. Groups of 10 COC-metaphase II or 50 metaphase II oocytes were collected, as described above, and were treated for 5 min in small Petri dishes containing a drop of M16 medium supplemented with 200 µM IBMX, under paraffin oil, in a humidified chamber at 37°C and 5% CO2. Stock solutions of 10 mM 5-carboxamidotryptamine maleate (5-CT; Tocris Cookson Inc., Ellisville, MO), 5-hydroxytryptamine creatinine sulfate complex (5-HT; Sigma-Aldrich), 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH DPAT; Tocris Cookson), or {alpha}-methyl 5-HT maleate ({alpha}-methyl-5-HT; Tocris Cookson) were prepared at 10 mM concentration in H2O and kept in aliquots at -20°C. Stock solutions of 2-[1-(4-piperonyl) piperazinyl]benzothiazole (PPB; Tocris Cookson) at 10 mM in DMSO, forskolin at 10 mM in DMSO, BAPTA-AM (Invitrogen) at 20 mM in DMSO, and ionomycin (Sigma-Aldrich) at 1 mM in ethanol were also prepared and kept the same way. One 10 mM aliquot of the appropriate drug was thawed and diluted before each experiment. In the BAPTA-containing conditions, groups of cells were incubated in M16 medium containing 50 µM BAPTA-AM and 0.02% Pluronic F-127 (Invitrogen) for 30 min under paraffin oil in a humidified chamber at 37°C and 5% CO2 before the 5-min treatment. Treatments were stopped by transfer of the cells with a minimum of medium to a new tube and its immersion in liquid nitrogen. The cells were kept at -80°C until cAMP extraction. Frozen cells were thawed and frozen in liquid nitrogen two more times to ensure complete lysis of the cells. Then, 100 µl of cold 95% ethanol/0.1% trichloroacetic acid was added to each tube, and the cells were centrifuged at 3000 rpm for 10 min at 4°C. The supernatant was evaporated, and the remaining pellet was resuspended in 50 µl of assay buffer (cAMP Biotrak enzyme immunoassay system kit; GE Healthcare). cAMP was measured according to the acetylation procedure described by the manufacturer.

Intracellular Ca2+ Measurement in Oocytes and Cumulus Cells. For cumulus cell Ca2+ measurements, COC-metaphase II were collected as described above and incubated in M2 medium containing 5 µM fura-2/acetoxymethyl ester and 0.02% Pluronic F-127 for 25 min at 37°C. After three washes in M2 medium, the COCs were transferred into a 100-µl plastic chamber containing M2 medium supplemented with 10 mg/ml bovine testis hyaluronidase on a poly(lysine) coverslip installed on the stage of an inverted microscope (Diaphot; Nikon, Tokyo, Japan). After a few minutes to allow dispersion of the cumulus cells and their adherence to the coverslip, the chamber was perfused (5 ml/min) with M2 medium until a stable baseline signal was obtained. M2 medium or M2 medium containing 10 nM, 100 nM, or 1 µM 5-HT, or 200 µM ATP maintained at 37°C was perfused at a rate of 5 ml/min throughout each experiment. For metaphase II oocyte measurements, oocytes without zona pellucida were prepared like cumulus cells but for the hyaluronidase-containing step. Fluorescence signals were obtained from a fluorescence lamp coupled to a high-speed filter changer (Lambda DG-4; Sutter Instrument Company, Novato, CA) and a refrigerated charge-coupled device camera (Photometrics Cool SNAP HQ; Roper Scientific, Trenton, NJ). Excitation wavelengths were 340 and 380 nm, and fluorescence emission was measured at 510 nm. The collected data were then analyzed by Metafluor program 6.1 (Universal Imaging Corporation, Downingtown, PA).

Statistical Analysis. The results of cAMP measurement are expressed as means ± S.E.M. Each experiment was performed at least three times in duplicate. Statistically significant differences between group means and the control mean were analyzed by unpaired Student's t test.


    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Expression of 5-HT2A and 5-HT7 Receptor mRNAs in COCs and Embryos. Adopting a nested RT-PCR strategy with oligonucleotides flanking intron sequences and specific for mouse 5-HT7 mRNA, we detected a band of the proper size in preparations from the ovary, cumulus cells, germinal vesicle stage oocytes, metaphase II oocytes, one-cell embryos, two-cell embryos, and four-cell embryos, but not in eight-cell embryos, morula, and blastocysts (Fig. 1A, top). Taking a similar RT-PCR approach for 5-HT2A mRNA, an amplified band of the expected size (confirmed by sequencing) was detected in mRNA preparations of ovary and cumulus cells but not in oocytes or preimplantation embryos of any developmental stage (Fig. 1A, middle).



View larger version (41K):
[in this window]
[in a new window]
 
Fig. 1. Expressions of 5-HT7 and 5-HT2A receptors mRNAs in cumulus cells, oocytes, and embryos, and C-terminal amino acid sequences of mouse, rat, and human 5-HT7 receptor isoforms. A, RT-PCR-amplified bands for 5-HT7 (isoforms a, b, and c), 5-HT2A receptors, and actin control obtained with mRNA extracted, respectively, from total ovaries (lane 1), isolated cumulus cells (lane 2), germinal vesicle stage oocytes (lane 3), metaphase II oocytes (lane 4), one-cell (lane 5), two-cell (lane 6), four-cell (lane 7), and eight-cell embryos (lane 8), morulae (lane 9), blastocysts (lane 10), and a representative negative control sample without cDNA (lane 11). Depicted bands, at their expected sizes as described under Materials and Methods, were the only ones detected in three to four separate determinations. B, comparison of the deduced C-terminal amino acids of the mouse isoforms with their rat and human homologs. Amino acid differences are underscored.

 
In addition to the known mouse 5-HT7 sequence, with which our band (called a) was identical (as verified by sequencing), we detected two additional isoforms (herein called isoforms b and c, sequences deposited in GenBank AY450670 [GenBank] and AY450671 [GenBank] ) that had not been described previously for the mouse but are homologous to rat isoforms b and c, which are known to result from alternative splicing (Heidmann et al., 1997Go). Mouse isoform a mRNA disappears by the eight-cell stage, whereas isoforms b and c disappear sooner, by the four- and two-cell stages, respectively (Fig. 1A, top).

Figure 1B compares the deduced C-terminal amino acid sequence of mouse, rat, and human 5-HT7 receptor isoforms. As described already, mouse and rat isoforms a are identical in their C-terminal region, whereas human isoform a differs for five amino acids (Fig. 1B, underlined). The isoform b that we identified in the mouse is identical with rat isoform b and differs only by one amino acid from the human sequence. For the last isoform, the C-terminal tail after the alternative splicing site differs between rats (isoform c) and humans (isoform d) and yields two different C-terminal sequences with no homology. The sequencing of this last isoform in the mouse showed expression of an isoform c, which differs only in six amino acids compared with the rat. As with rat isoform c, mouse isoform c has no homology with human isoform d (Fig. 1B).

Expression of 5-HT2B, 5-HT2C, 5-HT4, and 5-HT6 Receptor mRNAs in Metaphase II Oocytes and Cumulus Cells. A similar nested RT-PCR strategy was also conducted to verify the mRNA expression of the other Gq-coupled receptor subtypes, 5-HT2B and 5-HT2C, and Gs-coupled receptor subtypes, 5-HT4 and 5-HT6. None of these receptors could be detected in metaphase II oocytes (Fig. 2, lane 1). In cumulus cell preparations, the 5-HT2B receptor mRNA could be detected but not the 5-HT2C, 5-HT4, or 5-HT6 receptor mRNAs (Fig. 2, lane 2). Appropriate positive and negative controls were also conducted with brain preparations (Fig. 2, lane 3) and preparations without cDNAs for each receptor (Fig. 2, lane 4), respectively.



View larger version (41K):
[in this window]
[in a new window]
 
Fig. 2. Expressions of 5-HT2B, 5-HT2C, 5-HT4, and 5-HT6 receptor mRNAs in oocytes and cumulus cells. RT-PCR-amplified bands for 5-HT2B, 5-HT2C, 5-HT4, and 5-HT6 receptors and actin control obtained with mRNA extracted, respectively, from metaphase II oocytes (lane 1), isolated cumulus cells (lane 2), brain (lane 3), and a representative negative control sample without cDNA (lane 4). Depicted bands, at their expected sizes as described under Materials and Methods, were the only ones detected in three to four separate determinations.

 
Expression of 5-HT2A and 5-HT7 Receptor Proteins in COCs and Embryos. In addition to 5-HT7 and 5-HT2A mRNAs, we verified the presence of corresponding proteins by Western blotting and indirect immunofluorescence microscopy using specific antibodies for each receptor. Figure 3 depicts the positive detection of both receptors at expected size ranges with a common band (53 kDa) for 5-HT7 in cumulus cells and isolated oocytes (Fig. 3A) and a doublet of bands (51-63 kDa) for 5-HT2A in cumulus cells but not in oocytes (Fig. 3B). With the same antibodies under indirect immunofluorescence microscopy, COCs exhibited strong 5-HT2A-associated peripheral immunoreactivity in cumulus cells (Fig. 4A-A') but no staining of enclosed or isolated oocytes (Fig. 4, A-A' and B-B'), four-cell embryos (Fig. 4C-C'), or blastocysts (data not presented). No cell labeling was found when the anti-5-HT2A antibody had been depleted previously by preincubation with a 5-HT2A-blocking peptide or when only a secondary antibody was used (data not shown). In contrast, 5-HT7-associated immunoreactivity in COCs revealed strong oocyte labeling compared with weaker labeling at the periphery of cumulus cells (Fig. 5A-A'). Isolated oocytes also showed strong immunoreactive 5-HT7-labeling (Fig. 5B-B'). In four-cell embryos, in which 5-HT7 mRNA was at the limit of detection, we could still identify strong immunoreactivity associated with each blastomere (Fig. 5C-C'), whereas blastocysts, in agreement with our RT-PCR detecting no 5-HT7 mRNA, did not display any labeling with the anti-5-HT7 antibody (data not presented). In controls, no labeling of any cell type was seen when the first antibody was omitted (data not reported).



View larger version (37K):
[in this window]
[in a new window]
 
Fig. 3. Expressions of 5-HT7 and 5-HT2A proteins in cumulus cells and metaphase II oocytes. Western blots against samples from isolated oocytes (lane 1) or cumulus cells (lane 2) showing a common band at 53 kDa with an anti-5HT7 antibody (A) and doublet bands only in cumulus cells with an anti-5-HT2A antibody (B).

 


View larger version (81K):
[in this window]
[in a new window]
 
Fig. 4. Expression of 5-HT2A receptor protein in COCs, isolated metaphase II oocytes, and early embryos. Immunofluorescence of cells prepared with an anti-5-HT2A antibody (A'-C') and observed by confocal microscopy. Phase contrast (A-C) and corresponding fluorescence (A'-C') images of a mouse COC (A-A'), isolated metaphase II oocyte (B-B'), and four-cell stage embryo (C-C'). Scale bars, 10 µm.

 


View larger version (112K):
[in this window]
[in a new window]
 
Fig. 5. Expression of 5-HT7 receptor protein in COCs, isolated metaphase II oocytes, and early embryos. Immunofluorescence of cells prepared with an anti-5-HT7 antibody (A'-C') and observed by confocal microscopy. Phase contrast (A-C) and corresponding fluorescence (A'-C') images of a mouse COC (A-A'), isolated metaphase II oocyte (B-B'), and four-cell stage embryo (C-C'). Scale bars, 10 µm.

 
Serotonin- and Agonist-Induced cAMP Elevation in COCs. Because the 5-HT7 receptor is known to be coupled to an increase of cAMP through Gs (Shen et al., 1993Go), we measured cAMP levels of COCs and metaphase II oocytes after 5-HT treatments. COCs were treated for 5 min with different concentrations of 5-HT in M2 medium containing IBMX to inhibit endogenous phosphodiesterases. Treatments of COCs with 10 or 100 nM 5-HT produced, respectively, 19 and 29% increases in their cAMP content, but these differences were not statistically significant (Fig. 6A). Higher doses of 1 and 10 µM 5-HT resulted in significant increases of 67 (p < 0.01) and 79% (p < 0.001). Incubating isolated oocytes in M2 medium containing 1 or 10 µM 5-HT did not affect their cAMP content, whereas incubation in 10 µM forskolin resulted in a robust elevation of nearly 300% (Fig. 6B). Because 5-HT failed to increase the cAMP content of isolated oocytes, the cAMP increase observed in COCs is probably attributable to cumulus cells through activation of one or multiple 5-HT receptors.



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 6. Effect of 5-HT on the cAMP content of mouse COCs and isolated metaphase oocytes. COCs (A) and metaphase II oocytes (B) were submitted to different concentrations of 5-HT for 5 min in M2 medium containing 200 µM IBMX. A 10 µM forskolin treatment was included in the oocyte experiments. Mean results (± S.E.M.) of at least three duplicate experiments are shown. **, p < 0.01; ***, p < 0.001 compared with the control.

 

We thus decided to test the effect of different agonists on the cAMP content of COCs, targeting Gs-coupled 5-HT4, 5-HT6, and 5-HT7 receptors. We first used 5-CT, which has mixed 5-HT6 and 5-HT7 affinities (Shen et al., 1993Go; Kohen et al., 1996Go). Exposure to 1 or 10 µM 5-CT increased the cAMP content of COCs by 12 and 30%, respectively, with only the 10-µM dose yielding a significant increment (p < 0.01, Fig. 7A). With 1 or 10 µM 8-OH DPAT, a 5-HT1A and 5-HT7 agonist (Stam et al., 1992Go), the cAMP content of COCs increased by 18 and 36% (p < 0.05), respectively (Fig. 7B). Next, 1 or 10 µM PPB, a 5-HT4 agonist (Ramirez et al., 1997Go), did not significantly elevate the cAMP content of COCs (Fig. 7C). Finally, because cumulus cells also express 5-HT2A and 5-HT2B receptors, the 5-HT2 agonist {alpha}-methyl-5-HT (Baxter et al., 1995Go) was tested and induced increases in cAMP of 13 (1 µM) and 34% (10 µM, p < 0.01) (Fig. 7D). The estimated order of potency was thus 5-HT > 8-OH DPAT = {alpha}-methyl-5-HT = 5-CT > PPB, which excludes the possibility of a 5-HT4 receptor and strongly suggests the involvement of the 5-HT7 receptor, because 8-OH DPAT was able to evoke a cAMP increase, in agreement with our RT-PCR study in which the only Gs-coupled receptor mRNA detected was the 5-HT7 receptor (Figs. 1 and 2).



View larger version (30K):
[in this window]
[in a new window]
 
Fig. 7. Effect of 5-HT agonists on the cAMP content of mouse COCs. COCs were treated with 5-CT (A), 8-OH DPAT (B), PPB (C), or {alpha}-methyl-5-HT (D) for 5 min in M2 medium containing 200 µM IBMX. Mean results (± S.E.M.) of at least three duplicate experiments are shown. *, p < 0.05; **, p < 0.01; ***, p < 0.001 compared with control.

 

Serotonin-Induced Ca2+ Increase in COCs. Expression of the 5-HT2A and 5-HT2B receptor in cumulus cells led us to investigate the effect of 5-HT on the Ca2+ level of cumulus cells, because these receptors are known to be coupled to an increase in intracellular Ca2+ through Gq in other cell types. Dispersed cumulus cells were constantly perfused for the duration of the recording, and when adding 1 µM 5-HT, an increment of intracellular Ca2+ was detected in 56% of the cells (Fig. 8A and Table 1). At the end of each experiment, the cells were perfused with 200 µM ATP, and a strong Ca2+ increase was observed in 92% of them. This provided a positive control, because it is known that cumulus cells express a P2Y2 receptor whose activation results in Ca2+ increases (Webb et al., 2002aGo). Intracellular Ca2+ chelation with 50 µM BAPTA-AM before the 5-HT perfusion completely blocked the Ca2+ increase (Fig. 8D). Table 1 summarizes the characteristics of the 5-HT responses observed including the dose-response effect of 5-HT on the amplitude of the Ca2+ elevation (positive correlation, R2 = 0.081 and p < 0.0001), the percentage of reacting cells, and the effect of a BAPTA preincubation. The time delay of this Ca2+ increase was relatively short, occurring always within the first 12 s of perfusion with the 5-HT-containing solution. When a sharp spike was observed, it lasted for 20 to 25 s, and a long recovery time of approximately 60 s was needed to return to the original Ca2+ level. Experiments carried out with 100 or 10 nM 5-HT resulted in lower Ca2+ increases, but the time delay of the response, the duration of the peak, and recovery time were similar to the 1 µM dose response (Fig. 8, B and C, respectively). 5-HT at 1 nM was also tested, but clear Ca2+ increases were not detectable over the background (data not shown), and the 10 nM dose was considered the critical minimum concentration. It has been reported previously that in hamster oocytes, 5-HT triggers Ca2+ increases that are sensitive to 5-HT2 antagonists (Miyazaki et al., 1990Go). Even though we did not detect any 5-HT2 receptor in mouse oocytes, we decided to investigate the effect of 5-HT on the Ca2+ level of mouse oocytes. Perfusion with 10 µM 5-HT failed to elicit any Ca2+ upsurge (0/7, Table 1), even though these oocytes could respond to a 100 µM carbachol dose as a positive control (7/7).



View larger version (25K):
[in this window]
[in a new window]
 
Fig. 8. Effect of 5-HT on resting Ca2+ concentration in mouse cumulus cells. A typical trace of a cumulus cell response is shown when perfused with M2 medium containing 1 µM (A), 100 nM (B), or 10 nM 5-HT (C). Pretreatment of cumulus cells with 50 µM BAPTA-AM before the addition of 1 µM 5-HT blocks the Ca2+ increase (D). ATP (200 µM) was added at the end of each experiment as a positive control. Agonist perfusion time is indicated by the arrow, and its duration is indicated by the bar.

 

View this table:
[in this window]
[in a new window]
 
TABLE 1 Ca2+ measurement after 5-HT perfusion in mouse cumulus cells and oocytes Amplitude mean response presented as mean ± S.E.M.

 

Cross-Talk between Ca2+ and cAMP in COCs. Finally, because 5-HT regulates the cAMP and calcium levels of cumulus cells, we decided to investigate possible cross-talk between these two signaling pathways. When COCs were exposed to 5 µM ionomycin for 5 min to increase intracellular Ca2+, a 280% increase in their cAMP content was observed, indicating that solely augmenting intracellular Ca2+ somehow activated endogenous adenylate cyclase, resulting in elevated cAMP (Fig. 9A). This cAMP increment could be prevented by preincubation in the presence of BAPTA, confirming the Ca2+ specificity of this ionomycin-induced cAMP increase. We further evaluated whether ionomycin could increase the cAMP level of isolated oocytes. Figure 9B shows that the oocyte cAMP level is not affected by ionomycin, suggesting that the cAMP elevation in COCs is, in this condition, again attributable only to cumulus cells. When COCs were incubated in the presence of BAPTA before the 5-HT addition, the cAMP increment was limited to 36% (p < 0.01 versus control) rather than 60% (p < 0.001 versus control), but the difference between the two conditions was not statistically significant (Fig. 9A). Taken altogether, these results suggest that when COCs were incubated in the presence of BAPTA, the cAMP increase induced by 5-HT was somewhat lower but was still significant over untreated control cells (Fig. 9A). Part of the cAMP increase induced by 5-HT in cumulus cells could thus be caused by an augmentation of intracellular Ca2+. However, intracellular Ca2+ chelation does not preclude part of the 5-HT-induced increase in cAMP which, as expected, is largely Ca2+-independent.



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 9. Cross-talk between intracellular calcium concentration and cAMP in mouse COCs and metaphase II oocytes. Groups of cells (A, COCs; B, metaphase II oocytes) were treated with 1 µM 5-HT, 5 µM ionomycin, or 10 µM forskolin for 5 min in M2 medium containing 200 µM IBMX. Under BAPTA-containing conditions, the cells were pretreated for 30 min in 50 µM BAPTA-AM before the 5-min treatment. Mean results (± S.E.M.) of at least three duplicate experiments are shown. **, p < 0.01; ***, p < 0.001 compared with the control.

 


    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
This work extends our previous demonstration of a local serotonergic network in mouse cumulus-oocyte complexes and early embryos, including the presence of 5-HT itself, of the 5-HT synthesizing enzyme tryptophan hydroxylase in cumulus cells, and a 5-HT-specific uptake driven by a classic antidepressant-sensitive transporter within oocytes and embryos (Amireault and Dubé, 2005Go). We further show here that 5-HT might exert its local effect through 5-HT2A, 5-HT2B, and 5-HT7 receptors in cumulus cells, oocytes, and embryos and that 5-HT affects intracellular Ca2+ and cAMP in cumulus cells as expected from the activation of these identified receptors. Our work therefore completes the panel of required components for a local functional serotonergic network and confirms or extends scattered reports involving 5-HT in reproductive tissues or cells.

We have thus shown that 5-HT induces a dose-dependent increase of cAMP in mouse cumulus cells, most likely through a 5-HT7 receptor. This supports the previous demonstration that 5-HT could elevate the cAMP content of human granulosa-lutein cells in culture and their progesterone secretion through activation of a 5-HT7 receptor (Graveleau et al., 2000Go). The expression of a 5-HT7 receptor in these closely related cell types from two species suggests that it might be universally expressed in mammalian follicles. cAMP in granulosa cells is already known to transduce the effects of follicle-stimulating hormone and LH and, thus, turns on multiple distinct pathways, depending on the maturational stage of the follicle (Conti, 2002Go). Our present work adds 5-HT as a new potential intermediate in these processes turned on by cAMP. Our pharmacological and molecular studies further confirm this assumption, because 5-CT and 8-OH DPAT, both 5-HT7 agonists, could increase the cAMP content of cumulus cells, whereas 5-HT4 and 5-HT6 receptor mRNAs could not be detected in these cells.

We detected both mRNA and protein of the 5-HT7 receptor from germinal vesicle stage oocytes to four-cell embryos. However, after adding 5-HT to isolated metaphase II oocytes, in contrast to cumulus cells, none of the expected cAMP increment was detectable, suggesting little if any activity of the 5-HT7 receptor at this specific stage, which also shows internal rather than peripheral receptor immunostaining, a condition already reported for inactive and internalized 5-HT7 receptor in rat brain (Muneoka and Takigawa, 2003Go). Still, it remains possible that an oocyte 5-HT7 receptor might be active at earlier maturational stages when a tighter communication network with surrounding cells is most necessary to further oocyte progression. In this respect, recent evidence indicates that active maintenance of oocytes in prophase I, before ovulation, requires high cAMP, a tight communication with somatic cells, and constant Gs protein activity in mouse oocytes (Kalinowski et al., 2004Go; Mehlmann et al., 2004Go). This constant Gs protein activity was shown to rely on the orphan GPR3 receptor, because most oocytes (~90%) from Gpr3 knockout mice resume meiosis prematurely within antral follicles (Mehlmann et al., 2004Go). If an additional oocyte Gs-linked receptor were participating in the maintenance of meiotic arrest, as suggested by these authors (Mehlmann et al., 2004Go), at similar or (more likely) earlier follicular stages, then the Gs-linked 5-HT7 receptor reported here would be a candidate fulfilling some of the expected attributes with its ligand, 5-HT, being produced by neighboring somatic cells (Amireault and Dubé, 2005Go). On the other hand, whether the 5-HT7 receptor becomes functional at later stages (e.g., in cleavage-stage embryos) remains to be established. In this respect, it is noteworthy that 5-HT antagonists were reported to block or inhibit the progression of early cleavage divisions, whereas 5-HT prevents this effect (Buznikov et al., 1996Go), although other studies reported a negative effect on later blastocyst formation after exposure to 5-HT (Il'kova et al., 2004Go) or to the agonist sumatriptan (Vesela et al., 2003Go). Along this line, we detected three distinct 5-HT7 receptor isoforms in mouse oocytes and embryos that seem to be homologous to known rat (a, b, and c) or human (a and b) isoforms (Heidmann et al., 1997Go). Although these three isoforms were not found to differ significantly one with another in their pharmacological properties or functions (Heidmann et al., 1998Go), their respective abundance observed in various tissues in the rat (most abundant a, then b, then c isoform) seems conserved for mouse oocytes and embryos, with the sequential disappearance of the isoforms (c, b, then a), in our RT-PCR study, possibly reflecting an earlier decrease below a detectable threshold level of the least expressed isoforms in two- and four-cell embryos. Therefore, the reported serotonergic effects at the blastocyst stage are unlikely to be linked to the 5-HT7 receptor whose mRNA has long disappeared by that time but could be caused, as suggested, by a 5-HT1D receptor, whose effective expression would require additional confirmation (Vesela et al., 2003Go).

One surprising finding in cumulus cells was that the 5-HT2 agonist {alpha}-methyl-5-HT could also increase their cAMP content. However, this {alpha}-methyl-5-HT-induced cAMP increase might involve the observed cross-talk between Ca2+ and cAMP signaling in these cells. Indeed, the large increment of cAMP seen after ionomycin treatment of cumulus cells in COCs and blocked by BAPTA reveals a Ca2+-sensitive effect on cAMP levels. An elevation of intracellular Ca2+ could lead to such a cAMP increase through the activation of calmodulin-sensitive adenylate cyclase isoforms I and VIII (Taussig and Zimmermann, 1998Go). These adenylate cyclases have never been reported in mouse cumulus cells, but they are expressed in human granulosa cells (Asboth et al., 2001Go) and could link an {alpha}-methyl-5-HT-induced Ca2+ increase through a 5-HT2 receptor to increased cAMP. In addition, part of the 5-HT-evoked cAMP elevation in cumulus cells could be mediated by this Ca2+ increment because BAPTA-pretreated cells showed a smaller increase in cAMP after 5-HT addition.

We investigated the presence of 5-HT2A-B-C receptors in oocytes, embryos, and cumulus cells because of the known capacity of 5-HT to cause Ca2+ increases in hamster oocytes (Miyazaki et al., 1990Go; Fujiwara et al., 1993Go). Our various data clearly establish that none of the 5-HT2 receptors is expressed in oocytes, which is in agreement with the fact that their Ca2+ level is 5-HT-insensitive in the mouse, in contrast to the hamster (data not shown; S. Miyazaki, personal communication). Therefore, a species difference exists between the mouse and hamster that presumably reflects a differential expression of the 5-HT2 and/or 5-HT7 receptors in mammalian oocytes. Indeed, we have detected, by RT-PCR, 5-HT2A mRNA but not 5-HT7 mRNA in hamster metaphase II oocytes, whereas hamster cumulus cells express both subtypes as in the mouse (golden hamster 5-HT2A and 5-HT7 receptor cDNAs were cloned and sequenced; see GenBank accession numbers DQ015678 [GenBank] and DQ015679 [GenBank] ; P. Amireault and F. Dubé, unpublished data). This explains the observed Ca2+-mobilizing effect of 5-HT in hamster but not mouse oocytes and underscores the possibility of species differences in the type(s) of 5-HT receptors expressed in oocytes from diverse mammalian species. This also lends support to the possibility that human oocytes might indeed express a 5-HT2A receptor, as suggested by the detection of a 5-HT2A-specific expressed sequence tag (Neilson et al., 2000Go).

On the other hand, the expression of the 5-HT2A and 5-HT2B receptor in cumulus cells reveals that these receptors could be involved in follicle growth and steroidogenesis. Indeed, 5-HT has been demonstrated to stimulate estradiol secretion in rat preovulatory follicles, and this could be inhibited by ketanserin, a preferential 5-HT2A antagonist (Tanaka et al., 1993Go). In addition, 5-HT2A receptor densities increase in the rat forebrain at the time of the spontaneous estrogen-induced LH surge, compared with diestrous female rats (Sumner and Fink, 1997Go), whereas ovariectomy reduces 5-HT2A receptor mRNA and protein in the rat frontal cortex (Bethea et al., 1998Go). Thus, 5-HT2A receptors expressed in cumulus cells could promote steroidogenesis and could be regulated by steroids in a feedback loop, leading to coordinated follicle maturation. It seems likely that the Ca2+ responses of cumulus cells to 5-HT are largely mediated by a 5-HT2 receptor. Preliminary experiments showing that {alpha}-methyl-5-HT, an agonist for 5-HT2A-B-C receptors (Baxter et al., 1995Go), can induce calcium responses in cumulus cells further confirm this assumption (data not shown). Our RT-PCR analysis, showing the expression of 5-HT2A and 5-HT2B receptors but not of the 5-HT2C receptor, makes these two receptors likely candidates to generate the observed Ca2+ responses in cumulus cells. However, 5-HT can also evoke Ca2+ increases in human embryonic kidney 293 cells transfected with the 5-HT7 receptor (Baker et al., 1998Go). Hence, the activation of all three 5-HT receptors expressed by cumulus cells could generate, at least in part, the observed Ca2+ responses after 5-HT addition, even though this is not supported by the lack of effect of 8-OH DPAT on their Ca2+ levels (data not shown). The expression of 5-HT2A, 5-HT2B, and 5-HT7 receptors that we report here does not exclude the potential expression of other 5-HT receptor subtypes in both oocytes and cumulus cells other than the 5-HT2C, 5-HT4, and 5-HT6 receptors not detected here, with possible species differences, as mentioned earlier. Further investigations on this local ovarian serotonergic network should therefore include a more thorough survey of other potential 5-HT receptors that might be expressed, along with pharmacological analyses that are hindered by the heterogeneity of cell populations expressing multiple 5-HT receptors and exhibiting interconnected signaling pathways, such as that linking cAMP and Ca2+ increases.

In the in vivo context, the serotonergic network displayed in mouse COCs could be implicated in the autocrine and paracrine regulation of coordinated follicular growth known to involve bidirectional communication between the oocyte and the somatic compartment but through communicating channels still largely unresolved (Picton et al., 1998Go; Eppig, 2001Go). This local ovarian serotonergic network might regulate the cAMP and Ca2+ levels not only of cumulus cells but also of the oocytes themselves, either directly through their expressed 5-HT7 receptor or indirectly through the physical bridging with cumulus cells by gap junctions.

In conclusion, our work demonstrates that 5-HT can regulate the Ca2+ and cAMP levels of mouse cumulus cells, most likely through expressed 5-HT2A, 5-HT2B, and 5-HT7 receptors. In addition, oocytes and embryos up to the four-cell stage express the 5-HT7 receptor, but further work is needed to determine at which stage(s) this receptor is functional. Such uncovering of an ovarian local serotonergic network opens new avenues for understanding the intricate processes underlying follicle maturation, meiotic maturation, and, eventually, early embryonic development.


    Acknowledgements
 
We thank B. G. Allen and the Institut de Cardiologie de Montréal for providing access to their confocal microscope and L. R. Villeneuve for technical assistance with it. We acknowledge M. Sainte-Marie for help with collecting oocytes and embryos. We also thank Ovid Da Silva, Editor, Research Office, Research Centre, Centre Hospitalier de l'Universitié de Montréal, for editing this text.


    Footnotes
 
This work was supported by scholarships from Fonds de la recherche en santé du Québec, Fonds pour la formation de chercheurs et l'aide à la recherché, and the Université de Montréal (to P.A.), and by a Natural Sciences and Engineering Research Council of Canada grant (to F.D.).

Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.

doi:10.1124/mol.104.010124.

ABBREVIATIONS: LH, luteinizing hormone; 5-HT, 5-hydroxytryptamine; PCR, polymerase chain reaction; RT-PCR, reverse transcription-polymerase chain reaction; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; AM, acetoxymethyl ester; IBMX: 3-isobutyl-1-methylxanthine; COC, cumulus-oocyte complex; 5-CT, 5-carboxamidotryptamine maleate; 8-OH DPAT, 8-hydroxy-2-(di-n-propylamino) tetralin; PPB, 2-[1-(4-piperonyl) piperazinyl] benzothiazole; DMSO, dimethyl sulfoxide; {alpha}-methyl-5-HT, {alpha}-methyl-5-hydroxytryptamine maleate; D-PBS, Dulbecco's phosphate-buffered saline; bp, base pair(s).

Address correspondence to: Dr. François Dubé, Centre de recherche du Centre Hospitalier de l'Universitié de Montréal, Hôpital Saint-Luc 264, René-Lévesque Est, Montréal, Québec, Canada H2X 1P1. E-mail: francois.dube{at}umontreal.ca


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Amenta F, Vega JA, Ricci A, and Collier WL (1992) Localization of 5-hydroxytryptamine-like immunoreactive cells and nerve fibers in the rat female reproductive system. Anat Rec 233: 478-484.[CrossRef][Medline]

Amireault P and Dubé F (2005) Serotonin and its antidepressant-sensitive transport in mouse cumulus oocyte complexes and early embryos. Biol Reprod 73: 358-365.[Abstract/Free Full Text]

Asboth G, Price SA, Bellinger J, Ledger W, Barlow DH, and Bernal AL (2001) Characterization of adenylyl cyclases in cultured human granulosa cells. Reproduction 121: 217-228.[Abstract]

Baker LP, Nielsen MD, Impey S, Metcalf MA, Poser SW, Chan G, Obrietan K, Hamblin MW, and Storm DR (1998) Stimulation of type 1 and type 8 Ca2+/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor. J Biol Chem 273: 17469-17476.[Abstract/Free Full Text]

Barnes NM and Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38: 1083-1152.[CrossRef][Medline]

Battista PJ, Rexroad CE Jr, and Condon WA (1987) Mechanisms involved in the action of serotonin-induced stimulation of progesterone production by bovine luteal cells in vitro. Mol Cell Endocrinol 51: 145-151.[CrossRef][Medline]

Baxter G, Kennett G, Blaney F, and Blackburn T (1995) 5-HT2 receptor subtypes: a family re-united? Trends Pharmacol Sci 16: 105-110.[CrossRef][Medline]

Bethea CL, Pecins-Thompson M, Schutzer WE, Gundlah C, and Lu ZN (1998) Ovarian steroids and serotonin neural function. Mol Neurobiol 18: 87-123.[Medline]

Bodis J, Hartmann G, Torok A, Bognar Z, Tinneberg HR, Cledon P, and Hanf V (1993) Relationship between the monoamine and gonadotropin content in follicular fluid of preovulatory graafian follicles after superovulation treatment. Exp Clin Endocrinol 101: 178-182.[Medline]

Buznikov GA, Shmukler YB, and Lauder JM (1996) From oocyte to neuron: do neurotransmitters function in the same way throughout development. Cell Mol Neurobiol 16: 533-559.[CrossRef]

Cerda J, Subhedar N, Reich G, Wallace RA, and Selman K (1998) Oocyte sensitivity to serotonergic regulation during the follicular cycle of the teleost Fundulus heteroclitus. Biol Reprod 59: 53-61.[Abstract/Free Full Text]

Colas P and Dubé F (1998) Meiotic maturation in mollusc oocytes. Semin Cell Dev Biol 9: 539-548.[CrossRef][Medline]

Conti M (2002) Specificity of the cyclic adenosine 3',5'-monophosphate signal in granulosa cell function. Biol Reprod 67: 1653-1661.[Abstract/Free Full Text]

Conti M, Andersen CB, Richard F, Mehats C, Chun SY, Horner K, Jin C, and Tsafriri A (2002) Role of cyclic nucleotide signaling in oocyte maturation. Mol Cell Endocrinol 187: 153-159.[CrossRef][Medline]

Eppig JJ (2001) Oocyte control of ovarian follicular development and function in mammals. Reproduction 122: 829-838.[Abstract]

Fujiwara T, Nakada K, Shirakawa H, and Miyazaki S (1993) Development of inositol trisphosphate-induced calcium release mechanism during maturation of hamster oocytes. Dev Biol 156: 69-79.[CrossRef][Medline]

Gore-Langton RE and Armstrong DT (1988) Follicular steroidogenesis and its control, in Physiology of Reproduction (Knobil E and Neill J eds) pp 331-385, Raven Press, New York.

Graveleau C, Paust HJ, Schmidt-Grimminger D, and Mukhopadhyay AK (2000) Presence of a 5-HT7 receptor positively coupled to adenylate cyclase activation in human granulosa-lutein cells. J Clin Endocr Metab 85: 1277-1286.[Abstract/Free Full Text]

Hamblin MW, Guthrie CR, Kohen R, and Heidmann DE (1998) Gs protein-coupled serotonin receptors: receptor isoforms and functional differences. Ann NY Acad Sci 861: 31-37.[Abstract/Free Full Text]

Heidmann DE, Metcalf MA, Kohen R, and Hamblin MW (1997) Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization. J Neurochem 68: 1372-1381.[Medline]

Heidmann DE, Szot P, Kohen R, and Hamblin MW (1998) Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing. Neuropharmacology 37: 1621-1632.[CrossRef][Medline]

Il'kova G, Rehak P, Vesela J, Cikos S, Fabian D, Czikkova S, and Koppel J (2004) Serotonin localization and its functional significance during mouse preimplantation embryo development. Zygote 12: 205-213.[CrossRef][Medline]

Kalinowski RR, Berlot CH, Jones TL, Ross LF, Jaffe LA, and Mehlmann LM (2004) Maintenance of meiotic prophase arrest in vertebrate oocytes by a Gs protein-mediated pathway. Dev Biol 267: 1-13.[CrossRef][Medline]

Kline D and Kline JT (1992) Repetitive calcium transients and the role of calcium in exocytosis and cell cycle activation in the mouse egg. Dev Biol 149: 80-89.[CrossRef][Medline]

Kohen R, Metcalf MA, Khan N, Druck T, Huebner K, Lachowicz JE, Meltzer HY, Sibley DR, Roth BL, and Hamblin MW (1996) Cloning, characterization and chromosomal localization of a human 5-HT6 serotonin receptor. J Neurochem 66: 47-56.[Medline]

Lawrence Y, Ozil JP, and Swann K (1998) The effects of a Ca2+ chelator and heavy-metal-ion chelators upon Ca2+ oscillations and activation at fertilization in mouse eggs suggest a role for repetitive Ca2+ increases. Biochem J 123: 335-422.

Leung PC and Steele GL (1992) Intracellular signaling in the gonads. Endocr Rev 13: 476-498.[Abstract]

Mehlmann LM, Jones TL, and Jaffe LA (2002) Meiotic arrest in the mouse follicle maintained by a Gs protein in the oocyte. Science (Wash DC) 297: 1343-1345.[Abstract/Free Full Text]

Miyazaki S, Katayama Y, and Swann K (1990) Synergistic activation by serotonin and GTP analogue and inhibition by phorbol ester of cyclic Ca2+ rises in hamster eggs. J Physiol 426: 209-227.[Abstract/Free Full Text]

Muneoka KT and Takigawa M (2003) 5-Hydroxytryptamine7 (5-HT7) receptor immunoreactivity-positive "stigmoid body"-like structure in developing rat brains. Int J Dev Neurosci 21: 133-143.[CrossRef][Medline]

Neilson L, Andalibi A, Kang D, Coutifaris C, Strauss JF, Stanton JL, and Green DL (2000) Molecular phenotype of the human oocyte by PCR-SAGE. Genomics 63: 13-24.[CrossRef][Medline]

Picton H, Briggs D, and Gosden R (1998) The molecular basis of oocyte growth and development. Mol Cell Endocrinol 145: 27-37.[CrossRef][Medline]

Ramirez MJ, Garcia-Garayoa E, Romero G, Monge A, Roca J, Del Rio J, and Lasheras B (1997) VB20B7, a novel 5-HT-ergic agent with gastrokinetic activity. I. Interaction with 5-HT3 and 5-HT4 receptors. J Pharm Pharmacol 49: 58-65.[Medline]

Roth BL, Willins DL, Kristiansen K, and Kroeze WK (1998) 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function. Pharmacol Ther 79: 231-257.[CrossRef][Medline]

Shen Y, Monsma FJJ, Metcalf MA, Jose PA, Hamblin MW, and Sibley DR (1993) Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J Biol Chem 268: 18200-18204.[Abstract/Free Full Text]

Stam NJ, Van Huizen F, Van Alebeek C, Brands J, Dijkema R, Tonnaer JA, and Olijve W (1992) Genomic organization, coding sequence and functional expression of human 5-HT2 and 5-HT1A receptor genes. Eur J Pharmacol 227: 153-162.[CrossRef][Medline]

Stricker SA and Smythe TL (2000) Multiple triggers of oocyte maturation in nemertean worms: the roles of calcium and serotonin. J Exp Zool 287: 243-261.[CrossRef][Medline]

Sumner BE and Fink G (1997) The density of 5-hydoxytryptamine2A receptors in forebrain is increased at pro-oestrus in intact female rats. Neurosci Lett 234: 7-10.[CrossRef][Medline]

Tanaka E, Baba N, Toshida K, and Suzuki K (1993) Serotonin stimulates steroidogenesis in rat preovulatory follicles: involvement of 5-HT2 receptor. Life Sci 53: 563-570.[CrossRef][Medline]

Taussig R and Zimmermann G (1998) Type-specific regulation of mammalian adenylyl cyclases by G protein pathways. Adv Second Messenger Phosphoprotein Res 32: 81-98.[Medline]

Terranova PF, Uilenbroek JT, Saville L, Horst D, and Nakamura Y (1990) Serotonin enhances oestradiol production by hamster preovulatory follicles in vitro: effects of experimentally induced atresia. J Endocrinol 125: 433-438.[Abstract]

Vesela J, Rehak P, Mihalik J, Czikkova S, Pokorny J, and Koppel J (2003) Expression of serotonin receptors in mouse oocytes and preimplantation embryos. Physiol Res 52: 223-228.[Medline]

Webb RJ, Bains H, Cruttwell C, and Carroll J (2002a) Gap-junctional communication in mouse cumulus-oocyte complexes: implications for the mechanism of meiotic maturation. Reproduction 123: 41-52.[Abstract]

Webb RJ, Marshall F, Swann K, and Carroll J (2002b) Follicle-stimulating hormone induces a gap junction-dependent dynamic change in [cAMP] and protein kinase a in mammalian oocytes. Dev Biol 246: 441-454.[CrossRef][Medline]




This article has been cited by other articles:


Home page
EndocrinologyHome page
M. Sasseville, N. Cote, C. Vigneault, C. Guillemette, and F. J. Richard
3'5'-Cyclic Adenosine Monophosphate-Dependent Up-Regulation of Phosphodiesterase Type 3A in Porcine Cumulus Cells
Endocrinology, April 1, 2007; 148(4): 1858 - 1867.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.010124v1
68/6/1678    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal